Cargando…

Resource utilisation, costs and clinical outcomes in non-institutionalised patients with Alzheimer’s disease: 18-month UK results from the GERAS observational study

BACKGROUND: Alzheimer’s disease (AD), the commonest cause of dementia, represents a significant cost to UK society. This analysis describes resource utilisation, costs and clinical outcomes in non-institutionalised patients with AD in the UK. METHODS: The GERAS prospective observational study assess...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lenox-Smith, Alan, Reed, Catherine, Lebrec, Jeremie, Belger, Mark, Jones, Roy W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5124297/ https://www.ncbi.nlm.nih.gov/pubmed/27887645 http://dx.doi.org/10.1186/s12877-016-0371-6

Ejemplares similares

Potential cost savings to be made by slowing cognitive decline in mild Alzheimer’s disease dementia using a model derived from the UK GERAS observational study
por: Lenox-Smith, Alan, et al.
Publicado: (2018)

Disease Progression in Mild Dementia due to Alzheimer Disease in an 18-Month Observational Study (GERAS): The Impact on Costs and Caregiver Outcomes
por: Jones, Roy W., et al.
Publicado: (2017)

How to deal with missing longitudinal data in cost of illness analysis in Alzheimer’s disease—suggestions from the GERAS observational study
por: Belger, Mark, et al.
Publicado: (2016)

Representativeness of European clinical trial populations in mild Alzheimer’s disease dementia: a comparison of 18-month outcomes with real-world data from the GERAS observational study
por: Reed, Catherine, et al.
Publicado: (2018)

Caregiver Burden in Alzheimer's Disease: Differential Associations in Adult-Child and Spousal Caregivers in the GERAS Observational Study
por: Reed, Catherine, et al.
Publicado: (2014)

Determinants of time to institutionalisation and related healthcare and societal costs in a community-based cohort of patients with Alzheimer’s disease dementia
por: Belger, Mark, et al.
Publicado: (2018)

Excess Costs Associated with Possible Misdiagnosis of Alzheimer’s Disease Among Patients with Vascular Dementia in a UK CPRD Population
por: Happich, Michael, et al.
Publicado: (2016)

Costs and Resource Use Associated with Community-Dwelling Patients with Alzheimer’s Disease in Japan: Baseline Results from the Prospective Observational GERAS-J Study
por: Nakanishi, Miharu, et al.
Publicado: (2020)

Health care resource utilisation in primary care prior to and after a diagnosis of Alzheimer’s disease: a retrospective, matched case–control study in the United Kingdom
por: Chen, Lei, et al.
Publicado: (2014)

Disease progression and costs at the 3‐year follow‐up of the GERAS‐US study
por: Chandler, Julie M., et al.
Publicado: (2023)

Modelling and the Nation: Institutionalising Climate Prediction in the UK, 1988–92
por: Mahony, Martin, et al.
Publicado: (2016)

Towards institutionalised regionalism: the role of institutions and prospects for institutionalisation in ASEAN
por: Rattanasevee, Pattharapong
Publicado: (2014)

Costs of Early Stage Alzheimer’s Disease in the United States: Cross-Sectional Analysis of a Prospective Cohort Study (GERAS-US)(1)
por: Robinson, Rebecca L., et al.
Publicado: (2020)

Institutionalising sustainable development.
Publicado: (2007)

Institutionalising ELSA in the moment of breakdown?
por: Forsberg, Ellen-Marie
Publicado: (2014)

Development of GERAS DANcing for Cognition and Exercise (DANCE): a feasibility study
por: Hewston, Patricia, et al.
Publicado: (2022)

Role of the gerA operon in L-alanine germination of Bacillus licheniformis spores
por: Løvdal, Irene S, et al.
Publicado: (2012)

CBCT Assessment of Ethmoid Roof Variations through Keros, Gera, and TMS Classifications
por: Mahdian, Mina, et al.
Publicado: (2022)

Some Psychological Problems in "Institutionalising" Defectives
por: Laird, Isabel M.
Publicado: (1938)

De-institutionalisation and trans-institutionalisation - changing trends of inpatient care in Norwegian mental health institutions 1950-2007
por: Pedersen, Per Bernhard, et al.
Publicado: (2009)

Methodological challenges in assessing the impact of comorbidities on costs in Alzheimer’s disease clinical trials
por: Kahle-Wrobleski, Kristin, et al.
Publicado: (2014)

Describing the Sequence of Cognitive Decline in Alzheimer’s Disease Patients: Results from an Observational Study
por: Henneges, Carsten, et al.
Publicado: (2016)

L-alanine-induced germination in Bacillus licheniformis -the impact of native gerA sequences
por: Madslien, Elisabeth H, et al.
Publicado: (2014)

Healthcare costs and resource utilisation in bronchiectasis, asthma and COPD
por: Ronco, Raffaella, et al.
Publicado: (2023)

AUSTRALIA ANTIGEN (HBsAG) IN INSTITUTIONALISED SCHIZOPHRENICS
por: Chaudhury, S., et al.
Publicado: (1993)

Oral health and mortality risk in the institutionalised elderly
por: Marín-Zuluaga, Dairo J., et al.
Publicado: (2012)

Institutionalising electoral uncertainty and authoritarian regime survival
por: BERNHARD, MICHAEL, et al.
Publicado: (2019)

Reliability of coded data to identify earliest indications of cognitive decline, cognitive evaluation and Alzheimer’s disease diagnosis: a pilot study in England
por: Dell’Agnello, Grazia, et al.
Publicado: (2018)

An Observational Retrospective Matched Cohort Study of Healthcare Resource Utilisation and Costs in UK Patients with Moderate to Severe Osteoarthritis Pain
por: Abraham, Lucy, et al.
Publicado: (2022)

Observation of Patient and Caregiver Burden Associated with Early Alzheimer’s Disease in the United States: Design and Baseline Findings of the GERAS-US Cohort Study(1)
por: Robinson, Rebecca L., et al.
Publicado: (2019)

A prospective, multicentre study to assess frailty in elderly patients with leg ulcers (GERAS study)
por: Zorge, Nadja E., et al.
Publicado: (2022)

The hidden burden of adult allergic rhinitis: UK healthcare resource utilisation survey
por: Price, David, et al.
Publicado: (2015)

Healthcare resource utilisation and related costs of patients with CKD from the UK: a report from the DISCOVER CKD retrospective cohort
por: Pollock, Carol, et al.
Publicado: (2022)

INSTITUTIONALISED MENTALLY RETARDED IN A STATE MENTAL HOSPITAL
por: Somasundaram, O., et al.
Publicado: (1983)

Evaluating the institutionalisation of diversity outreach in top universities worldwide
por: Buenestado-Fernández, Mariana, et al.
Publicado: (2019)

Institutionalising global health: a call for ethical reflection
por: Sayeed, Sadath, et al.
Publicado: (2020)

Resource utilisation and costs in predementia and dementia: a systematic review protocol
por: Landeiro, Filipa, et al.
Publicado: (2018)

How useful is the EQ-5D in assessing the impact of caring for people with Alzheimer’s disease?
por: Reed, Catherine, et al.
Publicado: (2017)

Impact of multimorbidity on healthcare costs and utilisation: a systematic review of the UK literature
por: Soley-Bori, Marina, et al.
Publicado: (2020)

Social and economic costs and health-related quality of life in non-institutionalised patients with cystic fibrosis in the United Kingdom
por: Angelis, Aris, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_k7n1kaj9ceqp6lnsoj8cas9v1p